Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Completed 3

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 3

Conditions

Neoplasms 4Melanoma 4Skin Neoplasms 3Neoplasm Metastasis 2Tongue Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Otorhinolaryngologic Neoplasms 1Lip Neoplasms 1Laryngeal Diseases 1Head and Neck Neoplasms 1Carcinoma 1

Interventions

pembrolizumab 15Nivolumab 10Ipilimumab 7cemiplimab 6dabrafenib 4binimetinib 4Dacarbazine 4trametinib 3encorafenib 3Drug Therapy 3Allovectin-7 3zanolimumab 2talabostat 2lifileucel 2aldesleukin 2Vemurafenib 2Tablets 2Semaxinib 2Intravital Microscopy 2Interleukin-2 2Fluorouracil 2vitespin 1veliparib 1varlilumab 1tozuleristide 1tin etiopurpurin 1tilsotolimod 1spartalizumab 1sotigalimab 1sonidegib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Skin Neoplasms × Allovectin-7 × Clear all
NCT00003646 2011-07-07

Gene Therapy in Treating Patients With Stage III or Stage IV Melanoma

Vical

Phase 2 Completed
78 enrolled
Dermatologic

Melanoma, Neoplasms, Skin Neoplasms

NCT00044356 2011-07-07

Phase II Trial of Allovectin-7® for Metastatic Melanoma

Vical

Phase 2 Completed
133 enrolled
Dermatologic

Melanoma, Neoplasm Metastasis, Neoplasms, Skin Neoplasms

NCT00003647 2008-07-25

Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma

Vical

Phase 3 Completed
Dermatologic

Melanoma, Neoplasms, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡